Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Perioperative Glucose Management for Patients on Basal Insulin

Introduction to Perioperative Care

  • The American Diabetes Association recommends monitoring blood glucose at least every 2-4 hours while the patient is NPO, with more frequent monitoring overnight when hypoglycemia risk peaks 1, 2, 3
  • The American Diabetes Association suggests reducing the evening basal insulin dose by approximately 25% the night before surgery to achieve perioperative blood glucose goals with a lower risk for hypoglycemia 1, 6

Blood Glucose Monitoring Frequency

  • The American Diabetes Association explicitly recommends monitoring blood glucose "at least every 2-4 h while the individual takes nothing by mouth" 1
  • Earlier guidelines suggested every 4-6 hours, but this has been tightened to 2-4 hours in more recent recommendations 4, 5

Basal Insulin Dosing Adjustment

  • The American Diabetes Association recommends giving 75-80% of the usual long-acting analog dose the night before surgery to maintain euglycemia without requiring dextrose supplementation 1, 2, 3

Dextrose Infusion: When Is It Necessary?

  • D5 infusion is NOT routinely necessary for all NPO patients on basal insulin, but should be started if hypoglycemia occurs or is anticipated, particularly in patients at high risk for hypoglycemia 4, 1
  • The American Diabetes Association recommends starting D5 infusion if blood glucose falls below 70 mg/dL or is trending downward despite reduced basal insulin dose 2, 3, 7

Target Blood Glucose Range

  • The American Diabetes Association recommends maintaining perioperative blood glucose between 100-180 mg/dL to minimize the risk of hypoglycemia and hyperglycemia 1, 6
  • Stricter perioperative glycemic goals "may not improve outcomes and are associated with more hypoglycemia" 1, 6

Correction Insulin Protocol

  • The American Diabetes Association recommends using short- or rapid-acting insulin for correction doses as needed based on point-of-care glucose monitoring, with a target glucose level of less than 180 mg/dL 1, 2, 3
  • Administer correction insulin when glucose exceeds 180 mg/dL, and continue basal insulin coverage even while NPO 1, 4, 5, 7

Common Pitfalls to Avoid

  • The most critical error is failing to reduce the basal insulin dose the evening before surgery, which significantly increases hypoglycemia risk, particularly overnight when 78% of hypoglycemic episodes occur in patients on basal insulin 2, 3
  • Another common mistake is discontinuing basal insulin entirely while NPO, which leads to hyperglycemia and worse perioperative outcomes 4, 5, 7